primary antibodies against col1 Search Results


col1 primary antibody 20121  (Novotec Medical GmbH)
90
Novotec Medical GmbH col1 primary antibody 20121
Levels of significance ( p values) for two- and three-way interactions between estrous cycle phases, treatment time, and cathepsin G (CAT) or noscapine (NOSC) treatments in the analyses of relative transcript COL1A2 gene and <t> COL1 </t> protein relative abundance. The results were considered significant at p < 0.05.
Col1 Primary Antibody 20121, supplied by Novotec Medical GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/col1 primary antibody 20121/product/Novotec Medical GmbH
Average 90 stars, based on 1 article reviews
col1 primary antibody 20121 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
primers for the human fibrotic factors α-sma, col-1, and col-3  (Servicebio Inc)
90
Servicebio Inc primers for the human fibrotic factors α-sma, col-1, and col-3
Levels of significance ( p values) for two- and three-way interactions between estrous cycle phases, treatment time, and cathepsin G (CAT) or noscapine (NOSC) treatments in the analyses of relative transcript COL1A2 gene and <t> COL1 </t> protein relative abundance. The results were considered significant at p < 0.05.
Primers For The Human Fibrotic Factors α Sma, Col 1, And Col 3, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primers for the human fibrotic factors α-sma, col-1, and col-3/product/Servicebio Inc
Average 90 stars, based on 1 article reviews
primers for the human fibrotic factors α-sma, col-1, and col-3 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


Levels of significance ( p values) for two- and three-way interactions between estrous cycle phases, treatment time, and cathepsin G (CAT) or noscapine (NOSC) treatments in the analyses of relative transcript COL1A2 gene and COL1 protein relative abundance. The results were considered significant at p < 0.05.

Journal: Life

Article Title: The Inhibitory Effect of Noscapine on the In Vitro Cathepsin G-Induced Collagen Expression in Equine Endometrium

doi: 10.3390/life11101107

Figure Lengend Snippet: Levels of significance ( p values) for two- and three-way interactions between estrous cycle phases, treatment time, and cathepsin G (CAT) or noscapine (NOSC) treatments in the analyses of relative transcript COL1A2 gene and COL1 protein relative abundance. The results were considered significant at p < 0.05.

Article Snippet: The COL1 primary antibody (1:1000 diluted; RRID: AB_2891017, 20121, Novotec, Lyon, France) was incubated overnight at 4 °C and previously validated to equine endometrium by Rebordão et al. [ ].

Techniques: Isolation

Inhibition of cathepsin G (0.1 or 1 µg/mL) by noscapine (NOSC; 45 µg/mL) on relative collagen type I alpha 2 chain ( COL1A2 ) mRNA transcription and collagen type I (COL1) protein relative abundance in mare endometrial explants, regardless of estrous cycle phase and time of treatment. Results were considered significant at p < 0.05 and are displayed as least square means ± SEM. Different superscript letters indicate significant differences between CAT concentrations (a, b: CAT 0.1 µg/mL ≠ CAT 1 µg/mL, p < 0.05; c, d: CAT 0.1 µg/mL + NOSC ≠ CAT 1 µg/mL + NOSC, p < 0.05). Asterisks alone represent significant differences relative to the respective control and asterisks above the connecting lines indicate significant differences between treatments (** p < 0.01; *** p < 0.001).

Journal: Life

Article Title: The Inhibitory Effect of Noscapine on the In Vitro Cathepsin G-Induced Collagen Expression in Equine Endometrium

doi: 10.3390/life11101107

Figure Lengend Snippet: Inhibition of cathepsin G (0.1 or 1 µg/mL) by noscapine (NOSC; 45 µg/mL) on relative collagen type I alpha 2 chain ( COL1A2 ) mRNA transcription and collagen type I (COL1) protein relative abundance in mare endometrial explants, regardless of estrous cycle phase and time of treatment. Results were considered significant at p < 0.05 and are displayed as least square means ± SEM. Different superscript letters indicate significant differences between CAT concentrations (a, b: CAT 0.1 µg/mL ≠ CAT 1 µg/mL, p < 0.05; c, d: CAT 0.1 µg/mL + NOSC ≠ CAT 1 µg/mL + NOSC, p < 0.05). Asterisks alone represent significant differences relative to the respective control and asterisks above the connecting lines indicate significant differences between treatments (** p < 0.01; *** p < 0.001).

Article Snippet: The COL1 primary antibody (1:1000 diluted; RRID: AB_2891017, 20121, Novotec, Lyon, France) was incubated overnight at 4 °C and previously validated to equine endometrium by Rebordão et al. [ ].

Techniques: Inhibition, Control

Effect of cathepsin G (CAT; 0.1 or 1 µg/mL), noscapine (NOSC; 45 µg/mL), or CAT (0.1 or 1 µg/mL) + NOSC (45 µg/mL) treatments in explants of mare endometrium from follicular phase (FP) or mid-luteal phase (MLP) for 24 or 48 h on relative collagen type I alpha 2 chain ( COL1A2 ) mRNA transcription ( A , B ) and collagen type I (COL1) protein relative abundance ( C , D ). Results were considered significant at p < 0.05 and shown as least square means ± SEM. Asterisks alone represent significant differences relative to the respective control and asterisks above connecting lines indicate significant differences of CAT + NOSC treatment relative to the respective CAT-treated group (* p < 0.05; ** p < 0.01; *** p < 0.001).

Journal: Life

Article Title: The Inhibitory Effect of Noscapine on the In Vitro Cathepsin G-Induced Collagen Expression in Equine Endometrium

doi: 10.3390/life11101107

Figure Lengend Snippet: Effect of cathepsin G (CAT; 0.1 or 1 µg/mL), noscapine (NOSC; 45 µg/mL), or CAT (0.1 or 1 µg/mL) + NOSC (45 µg/mL) treatments in explants of mare endometrium from follicular phase (FP) or mid-luteal phase (MLP) for 24 or 48 h on relative collagen type I alpha 2 chain ( COL1A2 ) mRNA transcription ( A , B ) and collagen type I (COL1) protein relative abundance ( C , D ). Results were considered significant at p < 0.05 and shown as least square means ± SEM. Asterisks alone represent significant differences relative to the respective control and asterisks above connecting lines indicate significant differences of CAT + NOSC treatment relative to the respective CAT-treated group (* p < 0.05; ** p < 0.01; *** p < 0.001).

Article Snippet: The COL1 primary antibody (1:1000 diluted; RRID: AB_2891017, 20121, Novotec, Lyon, France) was incubated overnight at 4 °C and previously validated to equine endometrium by Rebordão et al. [ ].

Techniques: Control

Effect of cathepsin G (CAT; 0.1 or 1 μg/mL), noscapine (NOSC; 45 μg/mL), or CAT (0.1 or 1 μg/mL) + NOSC (45 μg/mL) treatments on relative collagen type I alpha 2 chain ( COL1A2 ) mRNA transcription ( A ) and collagen type I (COL1) protein relative abundance ( B ) in equine endometrial explants treated for 24 or 48 h, regardless of estrous cycle phase. Results are shown as least square means ± SEM and considered significant at p < 0.05. Asterisks above connecting lines indicate significant differences of the same treatment between time of treatment or differences between different concentrations of CAT at the same time of treatment (* p < 0.05; ** p < 0.01).

Journal: Life

Article Title: The Inhibitory Effect of Noscapine on the In Vitro Cathepsin G-Induced Collagen Expression in Equine Endometrium

doi: 10.3390/life11101107

Figure Lengend Snippet: Effect of cathepsin G (CAT; 0.1 or 1 μg/mL), noscapine (NOSC; 45 μg/mL), or CAT (0.1 or 1 μg/mL) + NOSC (45 μg/mL) treatments on relative collagen type I alpha 2 chain ( COL1A2 ) mRNA transcription ( A ) and collagen type I (COL1) protein relative abundance ( B ) in equine endometrial explants treated for 24 or 48 h, regardless of estrous cycle phase. Results are shown as least square means ± SEM and considered significant at p < 0.05. Asterisks above connecting lines indicate significant differences of the same treatment between time of treatment or differences between different concentrations of CAT at the same time of treatment (* p < 0.05; ** p < 0.01).

Article Snippet: The COL1 primary antibody (1:1000 diluted; RRID: AB_2891017, 20121, Novotec, Lyon, France) was incubated overnight at 4 °C and previously validated to equine endometrium by Rebordão et al. [ ].

Techniques:

Effect of cathepsin G (CAT; 0.1 or 1 μg/mL), noscapine (NOSC; 45 μg/mL), or CAT (0.1 or 1 μg/mL) + NOSC (45 μg/mL) treatments on relative collagen type I alpha 2 chain ( COL1A2 ) mRNA transcription ( A ) and collagen type I (COL1) protein relative abundance ( B ) in explants of mare endometrium from follicular (FP) or mid-luteal (MLP) phases, regardless of treatment time. Results are shown at least square means ± SEM and considered significant at p < 0.05. Asterisks above connecting lines indicate significant differences of the same treatment between estrous cycle phase or differences between different concentrations of CAT at the same estrous cycle phase (* p < 0.05; ** p < 0.01; *** p < 0.001).

Journal: Life

Article Title: The Inhibitory Effect of Noscapine on the In Vitro Cathepsin G-Induced Collagen Expression in Equine Endometrium

doi: 10.3390/life11101107

Figure Lengend Snippet: Effect of cathepsin G (CAT; 0.1 or 1 μg/mL), noscapine (NOSC; 45 μg/mL), or CAT (0.1 or 1 μg/mL) + NOSC (45 μg/mL) treatments on relative collagen type I alpha 2 chain ( COL1A2 ) mRNA transcription ( A ) and collagen type I (COL1) protein relative abundance ( B ) in explants of mare endometrium from follicular (FP) or mid-luteal (MLP) phases, regardless of treatment time. Results are shown at least square means ± SEM and considered significant at p < 0.05. Asterisks above connecting lines indicate significant differences of the same treatment between estrous cycle phase or differences between different concentrations of CAT at the same estrous cycle phase (* p < 0.05; ** p < 0.01; *** p < 0.001).

Article Snippet: The COL1 primary antibody (1:1000 diluted; RRID: AB_2891017, 20121, Novotec, Lyon, France) was incubated overnight at 4 °C and previously validated to equine endometrium by Rebordão et al. [ ].

Techniques: